Equity Rights Offering	3 Months Ended
Mar. 31, 2025
Warrants and Rights Note Disclosure [Abstract]
Equity Rights Offering	Note 10 – Equity Rights Offering In September 2020, the Corporation completed an equity rights offering, issuing 5,507,889 shares of its common stock and 12,339,256 Series A warrants to existing shareholders. The shares of common stock and warrants are classified as equity instruments in the condensed consolidated statements of shareholders’ equity. Each Series A warrant provides the holder with the right to purchase 0.4464 shares of common stock at an exercise price of $2.5668, or $5.75 per whole share of common stock, and expires on August 1, 2025. Series A warrants outstanding totaled 10,941,770 and 10,941,869 at March 31, 2025 and December 31, 2024, respectively.

Equity Rights Offering

3 Months Ended

Mar. 31, 2025

Warrants and Rights Note Disclosure [Abstract]

Note 10 – Equity Rights Offering

In September 2020, the Corporation completed an equity rights offering, issuing 5,507,889 shares of its common stock and 12,339,256 Series A warrants to existing shareholders. The shares of common stock and warrants are classified as equity instruments in the condensed consolidated statements of shareholders’ equity. Each Series A warrant provides the holder with the right to purchase 0.4464 shares of common stock at an exercise price of $2.5668, or $5.75 per whole share of common stock, and expires on August 1, 2025. Series A warrants outstanding totaled 10,941,770 and 10,941,869 at March 31, 2025 and December 31, 2024, respectively.